Dietary tartary buckwheat intake attenuates insulin resistance and improves lipid profiles in patients with type 2 diabetes: a randomized controlled trial
Tartary buckwheat (TB) is rich in protein, dietary fiber, and flavonoids has been reported to affect type 2 diabetes mellitus (T2DM) in animal experiments, but limited information is available on the benefit of TB as a whole food in T2DM patients. Thus, we tested the hypothesis that a daily replacement of a portion of the staple food with TB will improve risk factors of T2DM, including fasting glucose, insulin resistance, and lipid profile. In a parallel, randomized, open-label, controlled trial, 165 T2DM patients were randomly assigned to a control diet group (DC group, systematic diet plans and intensive nutritional education) or a TB intervention group (TB group, daily replacement of a portion of staple food with TB food).
Source: Nutrition Research - Category: Nutrition Authors: Ju Qiu, Yanping Liu, Yanfen Yue, Yuchang Qin, Zaigui Li Tags: Original Research Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Education | Endocrinology | Insulin | Nutrition | Universities & Medical Training